Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Viability assessment by delayed enhancement cardiovascular magnetic resonance: will low-dose dobutamine dull the shine?

Viability assessment by delayed enhancement cardiovascular magnetic resonance: will low-dose dobutamine dull the shine? Circulation. 2004 Jun 01; 109(21):2476-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.